High Peak, United Kingdom

David Alistair Scapens

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of David Alistair Scapens

Introduction: David Alistair Scapens is a trailblazing inventor based in High Peak, GB. His work in the field of therapeutic delivery mechanisms has earned him recognition and respect among his peers. With one patent to his name, Scapens is making significant contributions to medical science and innovation.

Latest Patents: Scapens holds a patent for the "Therapeutic delivery of carbon monoxide," which outlines compounds, pharmaceutical compositions, and methods aimed at the therapeutic delivery of carbon monoxide to humans and other mammals. His innovative method incorporates transition metal complexes with at least a substituted cyclopentadienyl, indenyl, or fluorenyl ligand and two or more carbonyl ligands, demonstrating a sophisticated approach to medical therapies.

Career Highlights: David is a key member of Hemocorm Limited, where he focuses on advancing research in therapeutic applications of carbon monoxide. His dedication and expertise in this emerging area of study position him as a leading figure in biomedical innovations.

Collaborations: Throughout his career, Scapens has worked alongside esteemed professionals such as Roberto Angelo Motterlini and Brian Ernest Mann. Their collaboration enhances the research and development initiatives at Hemocorm Limited and showcases a collective commitment to innovation in therapeutic solutions.

Conclusion: David Alistair Scapens stands out as an inventive force in the field of pharmaceutical sciences. Through his pioneering patent and collaborative efforts, he continues to push the boundaries of what is possible in therapeutic delivery methods, ultimately benefiting both humans and mammals alike.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…